HWP
TMO icon

Highline Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Highline Wealth Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.7K Buy
109
+41
+60% +$19.7K 0.01% 221
2026
Q1 		$33.5K Hold
68
– – 0.01% 221
2025
Q4 		$39.5K Buy
68
+9
+15% +$5.09K 0.01% 151
2025
Q3 		$28.7K Buy
59
+33
+127% +$15.4K 0.01% 217
2025
Q2 		$10.6K Sell
26
-3
-10% -$1.25K ﹤0.01% 324
2025
Q1 		$14.4K Buy
29
+8
+38% +$4.33K ﹤0.01% 247
2024
Q4 		$10.9K Sell
21
-17
-45% -$9.35K ﹤0.01% 239
2024
Q3 		$23.5K Buy
38
+20
+111% +$11.8K 0.01% 175
2024
Q2 		$9.96K Buy
18
+1
+6% +$573 ﹤0.01% 222
2024
Q1 		$9.88K Hold
17
– – ﹤0.01% 231
2023
Q4 		$9.02K Hold
17
– – ﹤0.01% 208
2023
Q3 		$8.61K Hold
17
– – 0.01% 193
2023
Q2 		$8.87K Hold
17
– – 0.01% 162
2023
Q1 		$9.8K Hold
17
– – 0.01% 161
2022
Q4 		$9.36K Hold
17
– – 0.01% 161
2022
Q3 		$8.62K Buy
+17
New +$9.51K 0.01% 144

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Highline Wealth Partners's TMO Position: Q2 2026 in Review

Highline Wealth Partners increased its Thermo Fisher Scientific (TMO) stake by 60% in Q2 2026, buying an estimated $19.7K and bringing the position to 109 shares worth $54.7K. The position accounts for 0.01% of the portfolio, ranked #221.

Highline Wealth Partners first reported a position in TMO in Q3 2022 and has held it in 16 quarters since. 517 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Highline Wealth Partners held 109 shares of Thermo Fisher Scientific worth $54.7K as of Q2 2026.
  • Highline Wealth Partners bought 41 Thermo Fisher Scientific shares in Q2 2026, an estimated $19.7K.
  • Thermo Fisher Scientific made up 0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #221 holding.
  • Highline Wealth Partners first reported a position in Thermo Fisher Scientific in Q3 2022 and has held it in 16 quarters since.
  • 517 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.